Eli Lilly raised its full-year profit and revenue forecasts on Thursday as strong international demand for weight-loss drugs ...
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...
( NewsNation) — The rate of adult obesity in the United States continued its gradual decline in 2025, as the use of GLP-1 ...
A woman has taken to the internet to share the biggest difference she experienced when switching between GLP-1 drugs Wegovy ...
Danish pharmaceutical giant Novo Nordisk, maker of weight-loss drugs Ozempic and Wegovy, announced Thursday an unsolicited ...
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...
Many need to stay slender to get acting roles or look good on stage, and medications such as Ozempic, Wegovy and Mounjaro ...
That is a sizeable increase on Pfizer's September offer of $47.50 upfront and $22.50 in CVRs, which combined to give a deal ...
Novo Nordisk raises its bid for obesity drugmaker Metsera to outmanoeuvre Pfizer, reshaping the fast-growing weight-loss ...
The Cochrane Database of Systematic Reviews has compared the long-term results from semaglutide (Ozempic, Wegovy) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback